image

The best stocks to buy since 1993

Latest issue now available

Synergy Health

December 2010

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 820p
The shares made it past £8 helped by strong interims. Revenue was up by 2% to £138m on a constant currency basis but pretax profit increased 26% to £14.9m producing a 22% increase in earnings to 25.1p. Operating margins rose 140 basis points to an all time record 14.9%, driven by improvements in gross margins to 37.8% that were supported by a tight lid on costs and the winding down of non-core business.As was the case previously, Synergy doesn’t report on a divisional basis although it supplies a limited divisional analysis. On the decontamination side, sales were said to be up 16%. In the UK there was 15% sales growth with NHS hospital volumes holding up. Overall Synergy said it expects to see annual growth in the UK return ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe